contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


levine-leichtman-capital-partners-opens-stockholm-office

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

LOS ANGELES, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today the hiring of Erik Nobel as a Managing Director...

LOS ANGELES, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today the hiring of Erik Nobel as a Managing Director, responsible for establishing and managing its newly opened office in Stockholm, Sweden. Mr. Nobel will lead LLCP’s structured equity origination and investing efforts in the Nordic region. According to Mike Weinberg, Partner and LLCP’s Head of European Investing, “We are very excited to welcome Erik to our team. His professional network and investing experience throughout Sweden, Norway, Denmark and Finland will be very valuable as we continue to expand our platform.  I have no doubt that Erik will be a critical part of our continued success.” Mr. Nobel joined LLCP in January 2019 and is a member of the Firm’s global originations group.  He will direct the sourcing of investment opportunities, as well as participate in due diligence and work with our local management teams post-transaction. Prior to joining LLCP, Mr. Nobel worked as an Investment Director at AP6, a state-owned pension fund specializing in managing unlisted equity assets. At AP6, he was responsible for co-sponsored and co-investment transactions, which included origination, evaluation and lead generation of direct investment opportunities throughout the Nordic region.  Previously, Mr. Nobel worked as a Deputy Director at IK Investment Partners in Stockholm and he began his career at J.P. Morgan in London as part of the Nordic M&amp;A team.  He has received a Master of Science degree in Business and Economics from Stockholm School of Economics. LLCP Stockholm Office Information Erik Nobel, Managing Director <a href="https://www.globenewswire.com/Tracker?data=F26Ih_wGg8OGkA154pnChJrq1vVDFz5vVWrOYfRWVL7uZUHJovP4iouxHC9pawrqFz_lfGqhV7imGxbyYB9H_w==">enobel@llcp.com</a> LLCP Sweden AB. Västra Trädgårdsgatan 15 111 53 Stockholm, Sweden +46 708 74 10 42 About Levine Leichtman Capital Partners LLCP is a Los Angeles, California based private investment firm that has managed approximately $10.2 billion of institutional capital since its inception.  LLCP invests in middle market companies located in the United States, the United Kingdom and Europe. LLCP is currently making new investments through Levine Leichtman Capital Partners VI, L.P., LLCP Lower Middle Market Fund, L.P., Levine Leichtman Capital Partners Europe, L.P., and Levine Leichtman Strategic Capital, LLC.  Current and prior investments by Levine Leichtman Capital Partners in Europe include CJ Fallon, ZorgDomein, SK Aerosafety, Squla, Mander Portman Woodward, GL Education, Law Business Research, Bluebird Care, etc.  LLCP has offices in Los Angeles, New York, Dallas, Chicago, Charlotte, London, Stockholm and The Hague. David Wolmer 310-275-5335 <img src="https://www.globenewswire.com/newsroom/ti?nf=NzQ5NzQwNiMyNzE2ODEwIzIwODc1ODY=" width="1" height="1"/>

Levine Leichtman Capital Partners Opens Stockholm Office

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Nordea Bank

Nordea shareholder? It’s easier than ever to attend the AGM with a new digital set-up

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation